Although T-DM1 treatment did not result in significant improvement of PFS, subgroup analyses showed a numerical trend of an increasing beneficial effect of T-DM1 in patients who had received HER-2-directed therapy or taxanes during early treatment 10 .
← all excerpts
Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells.
1
—
—